Personal profile

Biography

Prof Victoria Mar MBBS (Hons), FACD, PhD

Director of the Victorian Melanoma Service

Prof Victoria Mar is a Fellow of the Australasian College of Dermatologists and Director of the Victorian Melanoma Service at The Alfred Hospital. She is an NHMRC Early Career Fellow at the School of Public Health and Preventive Medicine, Monash University. 

She completed her PhD at Monash University/VMS and Peter MacCallum entitled ‘Clinical and molecular characteristics of aggressive melanoma’ (2014). She has an interest in early diagnosis and surveillance of high-risk individuals and supervises doctoral students in clinical and translational research projects.

She is a member of the Cancer Council Australia Melanoma Guidelines Working Group, is Clinical Lead for the Melanoma Clinical Outcomes Registry and Board member of the Melanoma and Skin Cancer Trials Group.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
  • The ACRF Centre for Dynamic Immuno-Oncology (CDIO)

    Shackleton, M. (Primary Chief Investigator (PCI)), Cherk, M. (Chief Investigator (CI)), Naranbhai, V. (Chief Investigator (CI)), McLean, C. (Chief Investigator (CI)), Monif, M. (Chief Investigator (CI)), Si Lun Tam, C. (Chief Investigator (CI)), Kalff, A. (Chief Investigator (CI)), Fleming, S. (Chief Investigator (CI)), Mar, V. (Chief Investigator (CI)), Ge, Z. (Chief Investigator (CI)) & Cheung, J. (Project Manager)

    7/04/257/01/30

    Project: Research

  • Data driven approaches to outsmart skin cancer

    Mar, V. (Primary Chief Investigator (PCI))

    1/01/2531/12/29

    Project: Research

  • Melanoma Research Victoria (MRV) Collaboration

    Mar, V. (Primary Chief Investigator (PCI)), McArthur, G. (Partner Investigator (PI)), Kee, D. (Partner Investigator (PI)), Underhill, C. (Partner Investigator (PI)), Vico-Alonso, C. (Chief Investigator (CI)), Ge, Z. (Chief Investigator (CI)), Yu, Z. (Chief Investigator (CI)), Button-Sloan, A. E. (Associate Investigator (AI)), Shackleton, M. (Associate Investigator (AI)), Trapani, J. A. (Associate Investigator (AI)), Fox, S. B. (Associate Investigator (AI)), Sandhu, S. (Associate Investigator (AI)), Dobrovic, A. (Associate Investigator (AI)), Neeson, P. J. (Associate Investigator (AI)), Gyorki, D. (Associate Investigator (AI)), Haydon, A. (Chief Investigator (CI)), Papenfuss , T. (Associate Investigator (AI)), Behren, A. (Associate Investigator (AI)), Hicks, R. J. (Associate Investigator (AI)), Parente, P. (Associate Investigator (AI)), Sheppard, K. E. (Associate Investigator (AI)), Underhill, C. (Associate Investigator (AI)), Harvey, K. (Associate Investigator (AI)), Speakman, D. (Associate Investigator (AI)), Kok, D. (Associate Investigator (AI)), Kelly, J. (Associate Investigator (AI)), Cebon , J. (Associate Investigator (AI)), Rao, A. (Associate Investigator (AI)) & Da Gama Duarte, J. (Associate Investigator (AI))

    28/03/2428/03/29

    Project: Research

  • The SiroSkin study: A multi-centre randomised double-blind placebo- controlled trial of 1% topical sirolimus in the chemoprevention of facial squamous cell carcinomas in solid organ transplant recipients

    Khosrotehrani, K. (Primary Chief Investigator (PCI)), Campbell, S. B. (Chief Investigator (CI)), Chambers, D. (Chief Investigator (CI)), Gordon, L. (Chief Investigator (CI)), Webster, A. C. (Chief Investigator (CI)), Mar, V. (Chief Investigator (CI)), Damian, D. (Chief Investigator (CI)), Chong, A. H. (Chief Investigator (CI)), Schaider, H. (Chief Investigator (CI)), Isbel, N. M. (Chief Investigator (CI)), McKenzie, S. (Associate Investigator (AI)), Gin, D. (Associate Investigator (AI)) & Soyer, P. (Associate Investigator (AI))

    1/02/2231/01/27

    Project: Research

  • Roadmap Options for Melanoma Screening in Australia (Melanoma-ROSA)

    Janda, M. (Primary Chief Investigator (PCI)), Cust, A. E. (Chief Investigator (CI)), Soyer, H. P. (Chief Investigator (CI)), Gillespie, N. (Chief Investigator (CI)), Gordon, L. (Chief Investigator (CI)), Ge, Z. (Chief Investigator (CI)), Betz-Stablein, B. D. (Associate Investigator (AI)), McInerney-Leo, A. M. (Associate Investigator (AI)), Lawn, C. (Associate Investigator (AI)), Fernandez-Peñas, P. (Associate Investigator (AI)), Canfell, K. (Associate Investigator (AI)), Mar, V. (Associate Investigator (AI)), Caffery, L. (Associate Investigator (AI)), Eriksson, A. (Associate Investigator (AI)) & Scolyer, R. A. (Associate Investigator (AI))

    NHMRC - National Health and Medical Research Council (Australia)

    1/01/2231/12/26

    Project: Research